<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/623EE08D-4CA8-4337-9D73-292C75362088"><gtr:id>623EE08D-4CA8-4337-9D73-292C75362088</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>PIRBRIGHT LABORATORY ASH ROAD , PIRBRIGHT</gtr:line1><gtr:city>WOKING</gtr:city><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:department>Biological Chemistry</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/63A7C928-3A19-4C14-812F-370961534DAC"><gtr:id>63A7C928-3A19-4C14-812F-370961534DAC</gtr:id><gtr:name>John Innes Centre</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:line3>Norwich</gtr:line3><gtr:line4>Norwich</gtr:line4><gtr:postCode>NR4 7UH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/623EE08D-4CA8-4337-9D73-292C75362088"><gtr:id>623EE08D-4CA8-4337-9D73-292C75362088</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>PIRBRIGHT LABORATORY ASH ROAD , PIRBRIGHT</gtr:line1><gtr:city>WOKING</gtr:city><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1B6DAEB7-4DAE-40CB-BF4B-9282C18B73D5"><gtr:id>1B6DAEB7-4DAE-40CB-BF4B-9282C18B73D5</gtr:id><gtr:firstName>George</gtr:firstName><gtr:otherNames>Peter</gtr:otherNames><gtr:surname>Lomonossoff</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FK01093X%2F1"><gtr:id>1623AB75-2340-4BFE-8B1F-17D351CCACC6</gtr:id><gtr:title>N-Cap RNA: protected RNAs for in-tube diagnostic controls and inter-laboratory standards</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/K01093X/1</gtr:grantReference><gtr:abstractText>Amplification of RNA from crude samples for diagnostic or screening purposes can fail at many stages during the isolation, clean-up and amplification processes. Such failures produce false negative results, which are not acceptable when screening critical samples, for instance during outbreaks of epidemic viral disease in animals or humans. It is therefore highly desirable, if not essential, to include control RNA at the earliest possible step in the process, so that a positive control signal can validate every step from sample acquisition to final amplification and detection. However RNA is a fragile molecule and an unprotected RNA standard is very rapidly degraded. We have shown that this degradation can be prevented by encapsulating the RNA within a plant virus particle (N-cap RNA) and, furthermore, that such particles can act as highly effective in-tube controls. We now need to develop methods for the rapid production of such controls for a wide range of target diseases.</gtr:abstractText><gtr:fund><gtr:end>2013-11-05</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-11-06</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>137512</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Pirbright Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Encapsiidate viral mimics</gtr:description><gtr:id>814E5107-FD4F-46EC-B667-037DDA1D2110</gtr:id><gtr:impact>Publication (Madi et al., 2015)

Design of further mimic constructs based on the technology developed during this project.

Use of the FMDV construct for diagnosis of infection and proficiency testing in sub-Saharan Africa.</gtr:impact><gtr:outcomeId>58bee7612c44d3.24245735-1</gtr:outcomeId><gtr:partnerContribution>The Pirbright Instituted tested encapsidated mimics containing sequences specific for foot and mouth disease virus (FMDV) and showed that they were effective in-tube positive controls for the diagnosis of FMDV in crude samples.</gtr:partnerContribution><gtr:piContribution>The team at JIC produced the virus particles containing deleted versions of cowpea mosaic virus (CPMV) RNA-2. The RNA within these particles is also modified to contain test sequences derived from animal virus pathogens that can be detected using PCR-based methods. The encapsidated mimic RNAs can act as in-tube positive controls for diagnostic and proficiency testing applications.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>12000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Institute Development Grant (IDG) Funding</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>John Innes Centre</gtr:fundingOrg><gtr:id>ED62ADE6-89F2-4678-AE39-D9AA40B74512</gtr:id><gtr:outcomeId>58beef46bda5e7.60946054</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The findings have been used to develop standards for use in diagnostic PCR reactions and for proficiency testing. They are making a vital contribution to the in-field diagnosis of infectious diseases.</gtr:description><gtr:id>5A95851A-9CAB-4E62-9AF5-372A701CE73E</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>54590b6b442e91.59322038</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have developed an efficient way of producing positive in-tube controls for real-time PCR-based diagnostic tests. These controls are based on a disabled version of cowpea mosaic virus (CPMV). The use of a disabled virus means that the controls can be deployed without the need for containment.</gtr:description><gtr:exploitationPathways>Originally the controls were intended for use in conjunction with veterinary diagnostic reactions but it is now clear they can be deployed in the human health sector.</gtr:exploitationPathways><gtr:id>BACE68DE-EFD5-4CC1-A025-FEB35D18BA66</gtr:id><gtr:outcomeId>54590ad0f15ec8.79135680</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A method for producing in-tube positive control reagents for diagnosis or proficiency testing. The method is based on using capsids of cowpea mosaic virus (CPMV) to protect RNAs from degradation in field samples, The encapsidated mimic RNA consists of a version of CPMV RNA-2 containing a deletion in the region encoding the viral movement protein (48K protein) plus sequences from the target pathogen which can be detected by PCR-based methods. The deletion in the 48K protein prevents spread of the virus in the environment. The method can be adapted as detection method for a wide variety of pathogens.</gtr:description><gtr:id>BA2E7555-86CF-4748-8314-2DD34E7EEA77</gtr:id><gtr:impact>The detection of foot and mouth disease virus (FMDV) and proficiency testing in sub-Saharan Africa</gtr:impact><gtr:outcomeId>58bef2306c9e23.36305085</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Encapsidated mimics</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3BFC2134-EBCA-42FD-AA6A-30605C894E9B</gtr:id><gtr:title>Development of a non-infectious encapsidated positive control RNA for molecular assays to detect foot-and-mouth disease virus.</gtr:title><gtr:parentPublicationTitle>Journal of virological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/713df4cef7c6cc96ab581d16736a4ae6"><gtr:id>713df4cef7c6cc96ab581d16736a4ae6</gtr:id><gtr:otherNames>Madi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0166-0934</gtr:issn><gtr:outcomeId>5675e23bdce41</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/K01093X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>